• India's patent office rejected the company's patent application, arguing the drug was not a new medicine but an amended version of its earlier product.

    NPR: Drug Maker Novartis Loses India Patent Battle

  • The news is a setback for Pfizer as it aims to build a large arsenal of anti-cancer medicines to help it grow earnings before big sellers like Lipitor, the top-selling medicine in the world, lose patent protection in coming years.

    FORBES: Magazine Article

  • The news is a setback for Pfizer (nyse: PFE - news - people ) as it aims to build a large arsenal of anti-cancer medicines to help it grow earnings before big sellers like Lipitor, the top-selling medicine in the world, lose patent protection in coming years.

    FORBES: Pfizer Stops Developing Coley Cancer Drug

  • On Wednesday, ViiV Healthcare a joint venture of GlaxoSmithKline, Pfizer, and Shionogi announced it would grant a voluntary license to the Medicines Patent Pool to enable low-cost supply of a key pediatric HIV medicine in the 118 countries in which 98.7% of all HIV-positive children reside.

    WHITEHOUSE: Medicines Patent Pool and ViiV Healthcare Collaborate for Children with HIV | The White House

  • Drugs, by contrast, are heavily reliant on patent protection to keep cheap, copycat generics at bay--and the patent clock starts ticking as soon as a medicine is invented.

    FORBES: Should P&G Sell Its Drug Business?

  • The patent on a new drug starts running out the second the medicine is invented, and it can take many, many years to get these big clinical trials done.

    FORBES: Two Ways To Fix The Drug Business

  • The goal: to create a drug that would prevent heart attacks and become a massive seller, potentially replacing Lipitor, the world's best-selling medicine, when it loses patent protection as early as 2010.

    FORBES

  • But turning that patent into applied medicine and profits will require the input of investors and managers as well as researchers.

    ECONOMIST: Biotechnology in Singapore

  • Pharmaceutical companies must worry less about squeezing additional profits from old medicines by copying the last successful drug and insisting on additional patent protections and focus more on new and innovative medicine.

    CNN: McCain's October 11, 2007, speech on health care

  • Since antianxiety medicine BuSpar went off-patent in April, for instance, sales of the drug have dropped 54%.

    FORBES: Drugs of Choice

  • This meant building a team of anywhere from ten to fifty people to deal with all the complexities of the process: chemistry, biology, regulatory affairs, clinical medicine, finance, business development, patent strategy, etc.

    FORBES: Virtual R&D: Drug Development In The New Millennium

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定